BioCentury
ARTICLE | Clinical News

Emisphere enrollment less than expected

September 14, 2000 7:00 AM UTC

EMIS said that it will not complete by year end its double-blind Phase III trial comparing its oral heparin with Lovenox from Aventis (AVE) to treat deep vein thrombosis. The company had initially tar...